Skip to main content
Premium Trial:

Request an Annual Quote

Vita Genomics and ITRI to Market Each Other's PGx Tools to Pharmas

NEW YORK (GenomeWeb News) — The Industrial Technology Research Institute and Vita Genomics will market their pharmacogenomics services to drug developers, Vita said today.
 
Under the agreement, the companies plan to offer Vita’s high-throughput sequencing, genotyping, and gene-expression profiling, and ITRI’s proteomics databases to pharmaceutical companies.
 
Both shops are based in Taiwan. Vita has a marketing operation in the US.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.